Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites

This study has been completed.
Information provided by:
Renovo Identifier:
First received: September 24, 2009
Last updated: NA
Last verified: September 2009
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2006
  Primary Completion Date: January 2006 (Final data collection date for primary outcome measure)